Evidence map›Paper›PMID 29634770›Full record

ArticlePloS one2018

Sesamin from Cuscuta palaestina natural plant extracts: Directions for new prospective applications.

Saleh Abu-Lafi, Sadam Makhamra, Ibrahim Rayan, Waseim Barriah, Ahmed Nasser, Basheer Abu Farkh, Anwar Rayan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Saleh Abu-LafiFaculty of Pharmacy, Al-Quds University, Abu-Dies, Palestine.
Sadam MakhamraChemistry Department, Faculty of Science and Technology, Al-Quds University, Abu-Dies, Palestine.
Ibrahim RayanInstitute of Applied Research-Galilee Society, Shefa-Amr, Israel.
Waseim BarriahAl-Qasemi College of Engineering & Science, Baka EL-Garbiah, Israel.
Ahmed NasserThe Interinstitutional Analytical Instrumentation Unit, the Volcani Center, ARO, Rishon LeZion, Israel.
Basheer Abu FarkhDrug Discovery Informatics Lab, QRC-Qasemi Research Center, Al-Qasemi Academic College, Baka El-Garbiah, Israel.
Anwar RayanInstitute of Applied Research-Galilee Society, Shefa-Amr, Israel.ORCID 0000-0001-8255-5947
Al-Qasemi Academic College of Education · ILAl-Quds University · PSAgricultural Research Organization · ILWestern Galilee College · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to disclose the potential bioactive components of Cuscuta palaestina, a native parasitic natural plant of flora palaestina and to open direction towards new prospective application. GC-MS analysis identified 18 components in the methanolic extract of C. palaestina for the first time. The most appealing among them are Sesamin and two other phytosterols (Campesterol and Stigmasterol), all of which are documented in the scientific literature for their anticancer activity. Quantitation of Sesamin extracted from C. palaestina by HPLC-PDA with the use of three organic solvents showed that the Sesamin content in the methanolic extract was the highest. Following the disclosure of Sesamin presence in C. palaestina, we raised the question of whether it is produced naturally in C. palaestina or acquired from the host plant. The quantitation of Sesamin in C. palaestina was performed while being with five different host plants, and was compared with the amount of Sesamin in C. palaestina grown alone. The findings reveal that Sesamin is an endogenous secondary metabolite in C. palaestina. Thus, further studies are required to prove if C. palaestina can be used as an alternative source of anticancer phytochemicals, mainly Sesamin, and if proteins in the Sesamin production pathway could be valid biological targets for the development of novel and selective pesticides for control/ eradication of C. palaestina and maybe some other Cuscuta species. As well, the findings from this study raise a big question of whether inferring Sesamin production in C. palaestina could reduce its attack ability to host plants.

Indexed as

CalibrationCuscutaDioxolesGas Chromatography-Mass SpectrometryLignansDioxolesLignanssesamin

Identifiers

PMID29634770
PMCPMC5892908
OpenAlexW2796650250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.